Wow. This is really very impressive.
How can they get this combo to market as quickly as possible? The compassionate use programme will be inundated now, surely.
Ann: Veyonda Survival Advantage in LuPSMA Therapy Confirmed, page-2
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.0¢ |
Change
0.015(14.3%) |
Mkt cap ! $35.06M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 12.0¢ | 10.5¢ | $28.47K | 247.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4392 | 11.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 57055 | 4 |
View Market Depth
| Last trade - 16.10pm 01/10/2024 (20 minute delay) ? |
| NOX (ASX) Chart |